Compound 1123
Identifiers
- Canonical SMILES:
CC(C)Cc1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cccc(Cl)c1
- InChi:
InChI=1S/C20H18Cl2N2O2/c1-12(2)9-17-23-18(20(25)26)19(13-5-3-6-14(21)10-13)24(17)16-8-4-7-15(22)11-16/h3-8,10-12H,9H2,1-2H3,(H,25,26)
- InChiKey:
NFMWGGXHBIXTQH-UHFFFAOYSA-N
External links
![]() 67954568 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.76 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 388.07 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 3.22 | |||
TPSA | 55.12 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 93 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.76 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5654 | Azeliragon | DB12689 | |
0.5252 | Olmesartan | DB00275 | |
0.4742 | N-6022 | DB12206 | |
0.4627 | Losartan | DB00678 | |
0.4591 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4550 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4500 | Telmisartan | DB00966 | |
0.4372 | Gluco-Phenylimidazole | DB02862 | |
0.4342 | Cimicoxib | DB05095 | |
0.4300 | Linsitinib | DB06075 | |
0.4194 | Ralimetinib | DB11787 | |
0.4178 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.4136 | Conivaptan | DB00872 | |
0.4107 | LY-2584702 | DB12690 | |
0.4071 | Flumazenil | DB01205 |